Collateral for a security interest recorded Jul 30, 2026 (Midcap Financial Trust).
Term ends Dec 29, 2026 · High confidence
20-year base term ends Dec 29, 2026
Held by Obagi Cosmeceuticals LLC
Filed Dec 29, 2006 as application 11/648,278 · Granted Jan 11, 2011
Base term, 20 years from filing
Today
2006
2026
Clock starts
Dec 29, 2006
Dec 29, 2006
Term ends
Dec 29, 2026
Dec 29, 2026
Granted
Jan 11, 2011
Jan 11, 2011
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 29, 2006, when this application, 11/648,278, was filed | Dec 29, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 29, 2026 | High confidence |
This family
| US 8,999,356 | In force Jul 2032 | Jul 2032 |
| US 7,390,431 | Term ended Mar 2026 | Mar 2026 |
| US 7,927,614 | Term ended no later than Jun 2026 | no later than Jun 2026 |
| Application 11/541,090 | Abandoned not computed | not computed |
| US 7,687,650 | In force Mar 2027 | Mar 2027 |
| US 7,976,854 | In force Jul 2028 | Jul 2028 |
| US 7,867,522 | this patent Dec 2026 | Dec 2026 |
| US 7,897,800 | In force no later than Jan 2027 | no later than Jan 2027 |
8 of 14 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
The 40 most recent of 45 recorded documents are shown; the 5 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 11, 2017 Reel 44829, frame 92 | Obagi Medical Products, Inc. | Obagi Cosmeceuticals LLC | Assignment of Assignor's Interest |
| Dec 12, 2018 Reel 47753, frame 914 | The Bank of New York Mellon | Obagi Medical Products, Inc. | Release of Security Interest |
| Dec 13, 2018 Reel 47873, frame 114 | Obagi Cosmeceuticals LLC | Wells Fargo Bank, National Association, as Administrative Agent | Notice of Grant of Security Interest in Patents |
| Mar 16, 2021 Reel 55613, frame 83 | Obagi Cosmeceuticals LLC | TCW Asset Management Company LLC, as Collateral Agent | Security Interest |
| Mar 19, 2021 Reel 55652, frame 735 | Wells Fargo Bank, National Association | Obagi Cosmeceuticals LLC | Release of Security Interest |
| Jul 29, 2022 Reel 60668, frame 771 | TCW Asset Management Company LLC | Obagi Cosmeceuticals LLC | Release of Security Interest |
| Aug 1, 2022 Reel 60690, frame 148 | Obagi Cosmeceuticals LLC | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Mar 18, 2025 Reel 70546, frame 595 | Obagi Cosmeceuticals LLC | TCW Asset Management Company LLC, as Administrative Agent | Security Interest |
| Mar 21, 2025 Reel 70592, frame 979 | Jpmorgan Chase Bank, N.a. | Obagi Cosmeceuticals LLC | Release of Security Interest |
| Apr 8, 2025 Reel 70778, frame 199 | Barclays Bank PLC, as Collateral Agent | Solta Medical, Inc.; Precision Dermatology, Inc.; Bausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited); Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Medicis Pharmaceutical Corporation; Humax Pharmaceutical S.A.; Solta Medical Ireland Limited; Bausch & Lomb Mexico, S.A. de C.V.; Bausch+lomb Ops B.V.; Bausch Health Americas, Inc.; Bausch Health Companies Inc.; Bausch Health Holdco Limited; Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC); Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia); Bausch Health US, LLC; Bausch Health, Canada Inc. / Sante Bausch, Canada Inc.; ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.); Orapharma, Inc.; Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.); Solta Medical Dutch Holdings B.V.; V-Bac Holding Corp.; VRX Holdco LLC; 1261229 B.C. Ltd.; 1530065 B.C. Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Precision Dermatology, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Salix Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Humax Pharmaceutical S.A. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch & Lomb Mexico, S.A. de C.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch+lomb Ops B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Holdco Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health, Canada Inc. / Sante Bausch, Canada Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Dutch Holdings B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | V-Bac Holding Corp. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | VRX Holdco LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1261229 B.C. Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1530065 B.C. Ltd. | Release of Security Interest |
| Nov 17, 2025 Reel 72928, frame 385 | TCW Asset Management Company LLC, as Administrative Agent | Obagi Cosmeceuticals LLC | Release of Security Interest |
| Nov 17, 2025 Reel 73625, frame 459 | Obagi Cosmeceuticals LLC | LSSF II Offshore Investments, LP, as Administrative Agent | Patent Security Agreement |
| Jul 30, 2026 Reel 75464, frame 639 | Obagi Cosmeceuticals LLC | Midcap Financial Trust, as Administrative Agent and Collateral Agent | Security Interest |
| Jul 30, 2026 Reel 76091, frame 953 | LSSF II Offshore Investments, LP | Obagi Cosmeceuticals LLC | Termination and Release of Security Interest in Patents |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2026
Term ends Dec 29, 2026. No further fees fall due before then
Citations
24
later US patents cite this one
That is top 25% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.